COST-EFFECTIVENESS ANALYSIS OF CEMIPLIMAB FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CARCINOMA IN SPAIN

被引：0
|
作者：
Sanchez-Marin, J. [1 ]
Leon, L. [2 ]
Sanchez-Hernandez, A. [3 ]
Uria, E. [1 ]
Nieves, D. [1 ]
机构：
[1] Pharmalex, Barcelona, Spain
[2] Complexo Hosp Univ Santiago Compostela SERGAS, Translat Med Oncol Oncomet, Hlth Res Inst Santiago IDIS, Santiago De Compostela, Spain
[3] Consorcio Hosp Prov Castellon, Castellon De La Plana, Spain
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE327
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [41] Cost-Effectiveness Analysis of Robotic-assisted Lobectomy for Non-Small Cell Lung Cancer
    Heiden, Brendan T.
    Mitchell, Joshua D.
    Rome, Eric
    Puri, Varun
    Meyers, Bryan F.
    Chang, Su-Hsin
    Kozower, Benjamin D.
    ANNALS OF THORACIC SURGERY, 2022, 114 (01): : 265 - 272
  • [42] International Cost-Effectiveness Analysis of Durvalumab in Stage III Non-Small Cell Lung Cancer
    Kareff, Samuel A.
    Han, Sunwoo
    Haaland, Benjamin
    Jani, Chinmay J.
    Kohli, Rhea
    Aguiar Jr, Pedro Nazareth
    Huang, Yiqing
    Soo, Ross A.
    Rodriguez-Perez, Angel
    Garcia-Foncillas, Jesus
    Domine, Manuel
    de Lima Lopes, Gilberto
    JAMA NETWORK OPEN, 2024, 7 (05) : E2413938
  • [43] COST-EFFECTIVENESS ANALYSIS OF EGFR MUTATION TEST FOR NON-SMALL CELL LUNG CANCER IN CHINA
    Jin, G.
    Yang, L.
    VALUE IN HEALTH, 2017, 20 (05) : A247 - A247
  • [44] Examining the cost and cost-effectiveness of adding bevacizumab to carboplatin and paclitaxel in advanced non-small cell lung cancer.
    Grusenmeyer, P. A.
    Gralla, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 314S - 314S
  • [45] Cost-Effectiveness of Pemetrexed for Advanced Non-Squamous Non-Small Cell Lung Cancer (nsNSCLC) in Patients Treated in a Spanish Institution
    Mielgo Rubio, Xabier
    Martinez Cabanes, Ruth
    Velastegui, Alejandro
    Rosero, Adriana
    Ruiz-Gimenez, Leticia
    Aguayo, Cristina
    Garcia Ferron, Maria
    Silva, Jorge
    Perez Fernandez, Elia
    Jara, Carlos
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S419 - S419
  • [46] Cost-effectiveness of diagnostic interventions. Non-small cell lung cancer
    Langer, A.
    ONKOLOGE, 2010, 16 (10): : 992 - +
  • [47] Cost-Effectiveness Analysis of Sintilimab Plus Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer: A Societal Perspective
    Li, Fuming
    Chen, Yingyao
    Xiao, Dunming
    Jiang, Shan
    Yang, Yi
    ADVANCES IN THERAPY, 2024, 41 (04) : 1436 - 1449
  • [48] Cost-Effectiveness Analysis of Sintilimab Plus Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer: A Societal Perspective
    Fuming Li
    Yingyao Chen
    Dunming Xiao
    Shan Jiang
    Yi Yang
    Advances in Therapy, 2024, 41 : 1436 - 1449
  • [49] Clinical benefit and cost-effectiveness analysis of liquid biopsy application in patients with advanced non-small cell lung cancer (NSCLC): a modelling approach
    Fabienne Englmeier
    Annalen Bleckmann
    Wolfgang Brückl
    Frank Griesinger
    Annette Fleitz
    Klaus Nagels
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 1495 - 1511
  • [50] Clinical benefit and cost-effectiveness analysis of liquid biopsy application in patients with advanced non-small cell lung cancer (NSCLC): a modelling approach
    Englmeier, Fabienne
    Bleckmann, Annalen
    Brueckl, Wolfgang
    Griesinger, Frank
    Fleitz, Annette
    Nagels, Klaus
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (04) : 1495 - 1511
12345